Back to Invesco Ltd. Invesco Ltd.

AXSMAXSM

Showing 8 of 28 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in Axsome Therapeutics, Inc.

Yes. Invesco holds 1,671,684 shares of AXSM (Axsome Therapeutics), worth $409.2M, as of its Q2 2026 13F filing. It increased the position by 374,006 shares (+28.8%) from Q1 2026. Invesco has held AXSM in every 13F on record since Q3 2019, 28 quarterly filings.

Current Value

$409.2M

Current Shares

1.7M

Total Value Change

+$353M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.7M
+28.8%
$409.2M0.0%$244.77
39
2026-Q1
Increased
1.3M
+1.9%
$219.3M0.0%$169.02
31
2025-Q4
Increased
1.3M
+28.6%
$232.6M0.0%$182.64
38
2025-Q3
Increased
990,557
+73.3%
$120.3M0.0%$121.45
45
2025-Q2
Decreased
571,549
-33.3%
$59.7M0.0%$104.39
0
2025-Q1
Increased
857,001
+23.8%
$100M0.0%$116.63
36
2024-Q4
Increased
692,464
+10.8%
$58.6M0.0%$84.61
33
2024-Q3
Increased
625,179
+12.1%
$56.2M0.0%$89.87
33

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used